Edgar Filing: Conroy James A

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Conroy James A

2. Issuer Name and Ticker or Trading Symbol
Symmetry Medical Inc. [SMA]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

C/O OLYMPUS PARTNERS, METRO CENTER, ONE STATION PLACE

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2006

(Street)

STAMFORD, CT 06902

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/15/2006		A		1,000 ⁽¹⁾	A	$ 0.0001	1,000	D
Common Stock	02/21/2006		J⁽²⁾		4,000,000	D	⁽²⁾	4,394,590	I ⁽³⁾ ⁽⁴⁾ ⁽⁵⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁵⁾
Common Stock	02/22/2006		X		19,034	A	$ 0.01	19,034	I ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾
Common Stock	02/22/2006		X		8,305	A	⁽⁶⁾	27,339	I ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾
Common Stock	02/22/2006		J⁽⁸⁾		27,339	D	⁽⁸⁾	0	I ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾
Common Stock	02/22/2006		X		1,056	A	$ 0.01	59,947	I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾
Common Stock	02/22/2006		X		460	A	⁽⁶⁾	60,407	I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾
Common Stock	02/22/2006		S		407	D	$ 22.14	60,000	I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾
Common Stock	02/22/2006		S		38,200	D	$ 22.15	21,800	I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾
Common Stock	02/22/2006		S		200	D	$ 22.16	21,600	I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾
Common Stock	02/22/2006		S		21,600	D	$ 22.2	0	I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾
Common Stock								555,946	I ⁽³⁾ ⁽⁴⁾ ⁽¹⁰⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽¹⁰⁾
Common Stock								2,280	I ⁽³⁾ ⁽⁴⁾ ⁽¹⁶⁾	See Footnote ⁽³⁾ ⁽⁴⁾ ⁽¹⁶⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Common Stock (Warrant right to buy)

$ 0.01

02/22/2006

X⁽¹²⁾

19,043

⁽¹¹⁾

06/11/2013

Common Stock

19,043

$ 0.01

I ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾

See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾

Common Stock (Warrant right to buy)

⁽⁶⁾

02/22/2006

X⁽¹³⁾

8,306

⁽¹¹⁾

06/11/2013

Common Stock

8,306

⁽⁶⁾

I ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾

See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁷⁾

Common Stock (Warrant right to buy)

$ 0.01

02/22/2006

X⁽¹⁴⁾

1,057

⁽¹¹⁾

06/11/2013

Common Stock

1,057

$ 0.01

I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾

See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾

Common Stock (Warrant right to buy)

⁽⁶⁾

02/22/2006

X⁽¹⁵⁾

461

⁽¹¹⁾

06/11/2013

Common Stock

461

⁽⁶⁾

I ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾

See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁹⁾

Common Stock (Warrant right to buy)

$ 0.01

⁽¹¹⁾

06/11/2013

Common Stock

88,282

I ⁽³⁾ ⁽⁴⁾ ⁽⁵⁾

See Footnote ⁽³⁾ ⁽⁴⁾ ⁽⁵⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Conroy James A C/O OLYMPUS PARTNERS, METRO CENTER ONE STATION PLACE STAMFORD, CT 06902	X

Signatures

/s/ James A. Conroy		02/23/2006
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Consists of restricted stock, beneficially owned directly by Mr. James A. Conroy, issued pursuant to the Issuer's 2004 Equity Incentive Plan. Shares vest ratably over a three year period as of December 31 of each year, beginning on December 31, 2006. As of this date, none of Mr. Conroy's shares of restricted stock have vested.
(2)	On February 21, 2006, Olympus Growth Fund III, L.P. made a pro-rata distribution of common stock, without consideration, to its partners, which includes OGP III, L.P., which received 501,308 shares.
(3)	Following the dispositions set forth in this Form 4, Olympus Growth Fund III, L.P. was the record owner of 4,394,590 shares of common stock and currently exercisable warrants to purchase 88,282 shares of common stock, OGP III, L.P. was the record owner 555,946 shares of common stock, OEF, L.P. was the record owner of 2,280 shares of common stock and Mr. Conroy directly owned 1,000 shares of common stock. (continued footnote 2)
(4)	Mr. James A. Conroy, a member of our board of directors, is a partner of the Olympus funds and has a pecuniary interest in certain of those shares. Mr. Conroy disclaims beneficial ownership of the common stock owned by the above entities, except to the extent of his proportionate pecuniary interest therein.
(5)	Represents shares or warrants, as applicable, directly owned by Olympus Growth Fund III, L.P. Shares beneficially owned by Olympus Growth Fund III, L.P. are beneficially owned indirectly by OGP III, LLC, its General Partner; by RSM, L.L.C., the Managing Member of OGP III, LLC; and by Mr. Robert S. Morris, the Managing Member of RSM, L.L.C.
(6)	Exercise price of .000128 per share.
(7)	Represents shares directly owned by Olympus Growth Co-Investment Fund III, L.P. Shares beneficially owned by Olympus Growth Co-Investment Fund III, L.P. are beneficially owned indirectly by OGP III, LLC, its General Partner; by RSM, L.L.C., the Managing Member of OGP III, LLC; and by Mr. Morris, the Managing Member of RSM, L.L.C.
(8)	On February 22, 2006, Olympus Growth Co-Investment Fund III, L.P. made a pro-rata distribution of common stock, without consideration, to its partners, which include OGP III, LLC, which received 1,810 shares.
(9)	Represents shares or warrants, as applicable, directly owned by Olympus Executive Fund, L.P. Shares beneficially owned by Olympus Executive Fund, L.P. are beneficially owned indirectly by OEF, L.P., its General Partner; by RSM, L.L.C., a General Partner of OEF, L.P.; and by Mr. Morris, the Managing Member of RSM, L.L.C.
(10)	Represents shares directly owned by OGP III, LLC. Shares beneficially owned by OPG III, LLC are beneficially owned indirectly by RSM, L.L.C., the managing member of OGP III, LLC; and by Mr. Morris, the Managing Member of RSM, L.L.C.
(11)	Currently exercisable.
(12)	The transaction being reported is a cashless exercise of warrants to purchase 19,043 shares of common stock, upon which 19,034 shares of common stock were issued.
(13)	The transaction being reported is a cashless exercise of warrants to purchase 8,306 shares of common stock, upon which 8,305 shares of common stock were issued.
(14)	The transaction being reported is a cashless exercise of warrants to purchase 1,057 shares of common stock, upon which 1,056 shares of common stock were issued.
(15)	The transaction being reported is a cashless exercise of warrants to purchase 461 shares of common stock, upon which 460 shares of common stock were issued.
(16)	Represents shares or warrants, as applicable, directly owned by OEF, L.P. Shares beneficially owned by OEF, L.P. are beneficially owned by RSM, L.L.C., its General Partner, and by Mr. Morris, the Managing Member of RSM, L.L.C.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.